UK health regulator approves Moderna COVID-19 shot for 12- to 17-year-olds

Britain’s health regulator has approved Moderna Inc’s COVID-19 vaccine for use in children aged 12 to 17 years, it said on Tuesday.

The approval comes more than two months after Pfizer Inc and German partner BioNTech’s COVID-19 vaccine got regulatory nod for use in children aged 12 to 15.

Moderna’s vaccine was recommended for use in adolescents by European regulators in July and is awaiting US authorisation. It is currently approved for people over the age of 18 in the UK.

Britain’s Joint Committee on Vaccination and Immunisation (JCVI) gave the go ahead on Aug. 4 for 16- and 17-year-olds to get their first dose of Pfizer’s COVID-19 vaccine ahead of schools returning in September.

JCVI will make a decision on whether the vaccine will be deployed or not.


The Dispatch is present across a number of social media platforms. Subscribe to our YouTube channel for exciting videos; join us on Facebook, Intagram and Twitter for quick updates and discussions. We are also available on the Telegram. Follow us on Pinterest for thousands of pictures and graphics. We care to respond to text messages on WhatsApp at 8082480136 [No calls accepted]. To contribute an article or pitch a story idea, write to us at [email protected] |Click to know more about The Dispatch, our standards and policies   

About the author

Avatar photo

The Dispatch Staff

Add Comment

Click here to post a comment